Osada H - Search Results

1

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: osada h. J Clin Oncol. 2004 Mar 1;22(5):811-9. doi: 10.1200/JCO.2004.04.109. J Clin Oncol. 2004. PMID: 14990636

2

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients.

Tomida S, Koshikawa K, Yatabe Y, Harano T, Ogura N, Mitsudomi T, Some M, Yanagisawa K, Takahashi T, Osada H, Takahashi T. Tomida S, et al. Among authors: osada h. Oncogene. 2004 Jul 8;23(31):5360-70. doi: 10.1038/sj.onc.1207697. Oncogene. 2004. PMID: 15064725

3

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

Osada H, Tatematsu Y, Saito H, Yatabe Y, Mitsudomi T, Takahashi T. Osada H, et al. Int J Cancer. 2004 Oct 20;112(1):26-32. doi: 10.1002/ijc.20395. Int J Cancer. 2004. PMID: 15305372

4

Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K, Mitsudomi T, Takahashi T. Takeuchi T, et al. Among authors: osada h. J Clin Oncol. 2006 Apr 10;24(11):1679-88. doi: 10.1200/JCO.2005.03.8224. Epub 2006 Mar 20. J Clin Oncol. 2006. PMID: 16549822

5

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.

Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, Takahashi T. Mizuno K, et al. Among authors: osada h. Oncogene. 2002 Apr 4;21(15):2328-33. doi: 10.1038/sj.onc.1205402. Oncogene. 2002. PMID: 11948416

6

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.

Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M, Takahashi T. Osada H, et al. Oncogene. 2002 Apr 4;21(15):2418-24. doi: 10.1038/sj.onc.1205303. Oncogene. 2002. PMID: 11948426

7

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.

Koshikawa K, Osada H, Kozaki K, Konishi H, Masuda A, Tatematsu Y, Mitsudomi T, Nakao A, Takahashi T. Koshikawa K, et al. Among authors: osada h. Oncogene. 2002 Apr 25;21(18):2822-8. doi: 10.1038/sj.onc.1205405. Oncogene. 2002. PMID: 11973641

8

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

Osada H, Takahashi T. Osada H, et al. Oncogene. 2002 Oct 21;21(48):7421-34. doi: 10.1038/sj.onc.1205802. Oncogene. 2002. PMID: 12379883 Review.

9

Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.

Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Among authors: osada h. Oncogene. 2002 Nov 28;21(54):8310-9. doi: 10.1038/sj.onc.1206014. Oncogene. 2002. PMID: 12447694

10

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.

Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, Takahashi T. Konishi H, et al. Among authors: osada h. Oncogene. 2003 Mar 27;22(12):1892-905. doi: 10.1038/sj.onc.1206304. Oncogene. 2003. PMID: 12660825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,172 results

Search Page

Filters